Skip to Main Content

Paper Details

Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Int J Clin Oncol
1
2023
Author NameAffiliation
Ayumi ShintaniGraduate School of Medicine, Osaka Metropolitan University
  • 1 - 1

Datasets

Release 1.2